Home 科学研究 天仙液人体临床试验
天仙液人體臨床試驗 打印 E-mail



Evaluation of the Safety and Efficacy of THL-P in Metastatic Breast Cancer

Sponsor: Taiwan THL Co.LTd.
Collaborator: National Taiwan University Hospital
Information provided by: Taiwan THL Co.LTd.
ClinicalTrials.gov Identifier: NCT00976365

  • Purpose:

    The purpose of this study is to obtain evidence from test article with efficacy in Metastatic Breast Cancer patients. The average of all changes from baseline to post-treatment evaluations in global health/quality of life (QoL) subscale assessed by self-administered European Organization for Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 (EORTC-QLQ-C30).



    © 2007-2014 Tombo Enterprise Sdn Bhd. Design by Aftersix Design Studio